Therapeutic Dose Assessment of Patient Switching from Atorvastatin to SimvastatinByGregory Hess, MD, MBA,Kafi N. Sanders, MPH,Jerrold Hill, PhD,Larry Z. Liu, MD, PhDJune 1st 2007
Racial Differences in Switching, Augmentation, and Titration of Lipid-lowering Agents by Medicare/Medicaid Dual-eligible PatientsByTami L. Mark, PhD, MBA,Kirsten J. Axelsen, MS,Lisa Mucha, PhD,Yelena Sadkova, MSJune 1st 2007
Epidemiology of Dyslipidemia and Economic Burden on the Healthcare SystemByDean G. Smith, PhDJune 1st 2007
